Rights and permissions
About this article
Cite this article
US FDA investigates rofecoxib DTC advertisements. Pharmacoecon. Outcomes News 392, 11 (2002). https://doi.org/10.1007/BF03279981
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279981